COVID-19 Vaccination Uptake and Hesitancy Among Current Tobacco Users.
COVID-19 Vaccination Uptake and Hesitancy Among Current Tobacco Users.
复制标题
DOI：
10.1177/1179173x211068027
复制
发表时间：
2021
影响因子：
2.2
通讯作者：
Yingst JM
中科院分区：
文献类型：
--
作者：
Krebs NM;D'Souza G;Bordner C;Allen SI;Hobkirk AL;Foulds J;Yingst JM
新型 mRNA 疫苗已经开发出来，并从 2020 年 12 月开始首先分发给美国的高危人群（包括吸烟者），以对抗冠状病毒 (COVID-19) 大流行。超过一半的美国成年人已经接种了至少 1 剂 COVID-19 疫苗，但许多其他人表示对接种疫苗犹豫不决。我们于 2021 年 4 月从宾夕法尼亚州成年吸烟者的便利样本中调查了 COVID-19 疫苗的接种情况和犹豫情况，此时距离烟草使用者有资格在该州接种疫苗大约 3 个月。参与者 (n = 231) 中 23.4% 为男性，90.5% 为白人，平均年龄为 48.1 (SD = 11.9) 岁。所有参与者均为当前吸烟者，大多数人 (90.9%) 报告当前吸烟，平均每天吸 16 支烟 (SD = 8.1)。近 60% (n = 137) 表示已接种至少 1 剂疫苗，而未接种疫苗的人 (n = 94) 中，84% (n = 79) 表示他们不太可能或非常不可能接种疫苗。未接种疫苗的人更有可能不消费有关 COVID-19 的新闻（卡方 P 值 < .01），并且不太可能相信政府新闻来源是有关 COVID-19 的可靠信息（卡方 P 值 < .01）。对疫苗犹豫不决的人的定性反应表达了对疫苗研究缺乏的担忧、对疫苗安全性的不信任以及对副作用的担忧。了解烟草使用者对疫苗的犹豫态度有助于制定有针对性的沟通策略，并直接解决相关问题，以促进这一人群中的疫苗接种，因为这些人群患上 COVID-19 严重并发症的风险可能会增加。
Novel mRNA vaccines have been developed and were first distributed to high-risk individuals (including smokers) in the United States starting in December 2020 to combat the coronavirus (COVID-19) pandemic. Over one-half of the U.S. adult population has received at least 1 dose of a COVID-19 vaccine, but many others have reported hesitation about becoming vaccinated. We examined COVID-19 vaccine uptake and hesitancy from a convenience sample of Pennsylvanian adult smokers in April 2021, approximately 3 months after tobacco users were eligible to receive vaccination in the state. Participants (n = 231) were 23.4% male, 90.5% white, and had a mean age of 48.1 (SD = 11.9) years. All participants were current tobacco users, with the majority reporting current cigarette smoking (90.9%) with an average of 16 (SD = 8.1) cigarettes smoked per day. Nearly 60% (n = 137) reported receiving at least 1 dose of the vaccine and of those who did not (n = 94), 84% (n = 79) said they were somewhat or very unlikely to get a vaccine. Those who were unvaccinated were more likely to not consume news about COVID-19 (chi-square P-value < .01) and less likely to believe government news sources as reliable information for COVID-19 (chi-square P-value < .01). Qualitative responses among those who were vaccine hesitant expressed concerns about the lack of research on the vaccine, distrust of the safety of the vaccine, and fears about side effects. Understanding vaccine hesitancy among tobacco users can help develop targeted communication strategies and directly address concerns to promote vaccination among this population who may be at an increased risk of severe complications from COVID-19.